Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Volume: 380, Issue: 24, Pages: 2295 - 2306
Published: Jun 13, 2019
Abstract
Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2...
Paper Details
Title
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Published Date
Jun 13, 2019
Volume
380
Issue
24
Pages
2295 - 2306
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History